92 related articles for article (PubMed ID: 21568966)
1. Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies.
Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
J Am Geriatr Soc; 2011 May; 59(5):936-8. PubMed ID: 21568966
[No Abstract] [Full Text] [Related]
2. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
[TBL] [Abstract][Full Text] [Related]
3. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
[TBL] [Abstract][Full Text] [Related]
4. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
[TBL] [Abstract][Full Text] [Related]
6. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
Kung FC; Ishii R; Liu HC; Takeda M
Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
[TBL] [Abstract][Full Text] [Related]
7. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
[TBL] [Abstract][Full Text] [Related]
8. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms.
Kimura T; Hayashida H; Furukawa H; Takamatsu J
Psychiatry Clin Neurosci; 2010 Apr; 64(2):207-10. PubMed ID: 20447015
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies.
Shinno H; Utani E; Okazaki S; Kawamukai T; Yasuda H; Inagaki T; Inami Y; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1543-5. PubMed ID: 17688986
[No Abstract] [Full Text] [Related]
11. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.
Iwasaki K; Maruyama M; Tomita N; Furukawa K; Nemoto M; Fujiwara H; Seki T; Fujii M; Kodama M; Arai H
J Clin Psychiatry; 2005 Dec; 66(12):1612-3. PubMed ID: 16401166
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
Mori S; Mori E; Iseki E; Kosaka K
Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
[TBL] [Abstract][Full Text] [Related]
13. Is Charles Bonnet syndrome an early stage of dementia with Lewy bodies?
Hanyu H; Takasaki A; Sato T; Akai T; Iwamoto T
J Am Geriatr Soc; 2008 Sep; 56(9):1763-4. PubMed ID: 19166452
[No Abstract] [Full Text] [Related]
14. Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells.
Kawakami Z; Kanno H; Ikarashi Y; Kase Y
J Ethnopharmacol; 2011 Mar; 134(1):74-81. PubMed ID: 21130853
[TBL] [Abstract][Full Text] [Related]
15. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D
Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795
[TBL] [Abstract][Full Text] [Related]
16. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies.
Sato S; Mizukami K; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1130-1. PubMed ID: 20420876
[No Abstract] [Full Text] [Related]
18. Effectiveness of Japanese herbal medicine yokukansan for alleviating psychiatric symptoms after traumatic brain injury.
Saito S; Kobayashi T; Osawa T; Kato S
Psychogeriatrics; 2010 Mar; 10(1):45-8. PubMed ID: 20594286
[TBL] [Abstract][Full Text] [Related]
19. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
Burn DJ; McKeith IG
Mov Disord; 2003 Sep; 18 Suppl 6():S72-9. PubMed ID: 14502659
[TBL] [Abstract][Full Text] [Related]
20. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
Frank C
Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
